SCHEMBL29430744

SCHEMBL29430744

Cc1oncc1-c1ccc(-c2cccs2)c(N)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 3/20 0.55
KCNH2 Q12809 1/20 0.44
L3MBTL1 Q9Y468 3/20 0.39
MAPT P10636 2/20 0.39
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
ALDH1A1 P00352 2/20 0.37
NFKB1 P19838 2/20 0.37
NFKB2 Q00653 2/20 0.37
RELA Q04206 2/20 0.37
LMNA P02545 2/20 0.37
MAPK1 P28482 2/20 0.37
TP53 P04637 1/20 0.37
ADORA1 P30542 3/20 0.37
ATM Q13315 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HDAC1 Q13547 2/20 0.35
HDAC2 Q92769 2/20 0.35
HDAC3 O15379 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22636874 1.00 TDO2 (0.55) TDO2KCNH2L3MBTL1MAPTNPC1
SCHEMBL22648115 0.81 BRD4 (0.36) TDO2L3MBTL1MAPTNPC1RAB9A
SCHEMBL22637149 0.79 TDO2 (0.51) TDO2L3MBTL1MAPTALDH1A1LMNA
SCHEMBL29430767 0.79 TDO2 (0.51) TDO2L3MBTL1MAPTALDH1A1LMNA
SCHEMBL22636777 0.78 TDO2 (0.36) TDO2L3MBTL1MAPTLMNAMAPK1
SCHEMBL22637035 0.78 BRD4 (0.37) TDO2L3MBTL1MAPTMAPK1BRD4
SCHEMBL22648208 0.77 KCNH2 (0.45) TDO2KCNH2NPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL22636634 0.76 KCNH2 (0.44) TDO2KCNH2NPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL29430632 0.76 KCNH2 (0.44) TDO2KCNH2NPC1RAB9ASMN1; SMN2
SCHEMBL22636714 0.75 MAPK1 (0.44) TDO2L3MBTL1MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3966196-A1 PHENYL-SULFAMOYL.BENZOYC ACIDS AS ERAP1 MODULATORS Grey Wolf Therapeutics Limited (GB) 2022-03-16 EP disclosed